Study guide
4.6 Adrenal Crisis and Incretin/Endocrine Emergencies
Certified Flight Paramedic FP-C
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Safety and Transport
1.1 Pre-Flight Operations and Equipment Stowing 1.2 Scene Safety and Landing Zone Management 1.3 In-Flight Emergency Response and Abort Protocols 1.4 Post-Incident Survival and Rescue Operations
2 Chapter 2: Flight Physiology
2.1 Gas Laws in Transport Medicine 2.2 Hypoxia: Classification and Corrective Actions 2.3 Environmental Stressors of Flight and Cabin Pressurization
3 Chapter 3: Airway, Anesthesia, and Analgesics
3.1 Advanced Airway Assessment and Difficult Airway Algorithms 3.2 Rapid Sequence Intubation (RSI) and Medication Selection 3.3 Mechanical Ventilation: Modes, Settings, and Monitoring 3.4 Transport Oxygen Systems and Duration Calculations 3.5 Anaesthetics and Induction Agents 3.6 Neuromuscular Blocking Agents 3.7 Analgesics and Vasoactive Sedative Titration
4 Chapter 4: Medical Emergencies
4.1 Respiratory Failure Pathologies (ARDS, Asthma, COPD) 4.2 Sepsis and Septic Shock Management 4.3 Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS) 4.4 Toxicological Emergencies and Overdose Antidotes 4.5 Environmental Emergencies: Core Temperature Control (Hypo/Hyperthermia) 4.6 Adrenal Crisis and Incretin/Endocrine Emergencies
5 Chapter 5: Neurological Emergencies
5.1 Neurological Assessment and GCS Motor Scales 5.2 Traumatic Brain Injury (TBI) and Intracranial Pressure (ICP) Management 5.3 Stroke Care: Hemorrhagic vs. Ischemic Thrombectomy Candidates 5.4 Status Epilepticus Seizure Protocols 5.5 Spinal Trauma and Spinal Cord Syndromes
6 Chapter 6: Cardiac Emergencies
6.1 Acute Coronary Syndrome (ACS) and 12-Lead Interpretation 6.2 Dysrhythmias: Bradycardias and High-Grade AV Blocks 6.3 Cardiogenic Shock and Systemic Vascular Resistance (SVR) 6.4 Vasoactive Medication Titration (Norepinephrine, Epinephrine, Dopamine) 6.5 Mechanical Circulatory Support (IABP and ECMO Transport) 6.6 Post-Cardiac Arrest Care and Targeted Temperature Management
7 Chapter 7: Trauma/Burn Resuscitation
7.1 Damage Control Resuscitation and the Lethal Triad 7.2 Hemorrhage Control and Massive Transfusion Protocols (MTP) 7.3 Penetrating Thoracic Trauma and Cardiac Tamponade (Beck's Triad) 7.4 Blunt Force Deceleration Injuries (Traumatic Aortic Rupture) 7.5 Burn Physiology: Calculations (Parkland Formula) and Escharotomy
8 Chapter 8: Maternal, Fetal, and Neonatal Emergencies
8.1 Perinatal Transport and Maternal Complications 8.2 Ob/Gyn Emergencies and Emergency Delivery 8.3 Neonatal Resuscitation Program (NRP) Standards
9 Chapter 9: Pediatric Emergencies
9.1 Pediatric Assessment Triangle and Pathophysiology 9.2 Pediatric Airway and Ventilatory Management 9.3 Pediatric Pharmacology and Dosing Calculations 9.4 Pediatric Trauma and Resuscitation
10 Chapter 10: Professional Considerations
10.1 CAMTS Standards and Quality Metrics 10.2 Medical Ethics and Transport Law (EMTALA) 10.3 Crew Resource Management (CRM) and Human Factors
4.6 Adrenal Crisis and Incretin/Endocrine Emergencies
Key Takeaways Explain This Topic AI
Adrenal crisis presents as distributive shock refractory to fluids and vasopressors, accompanied by hypoglycemia, hyponatremia, and hyperkalemia; treatment requires D5NS resuscitation and IV Dexamethasone or Hydrocortisone.
In suspected but undiagnosed adrenal crisis, Dexamethasone (4 mg IV) is the preferred steroid because it does not cross-react with cortisol assays, preserving the accuracy of subsequent ACTH stimulation testing.
In adult DKA or HHS (2024 consensus), insulin must be withheld if serum potassium is below 3.5 mEq/L, and potassium must be repleted first to avoid triggering fatal cardiac dysrhythmias.
Thyroid storm treatment requires a strict sequential protocol: block sympathetic hyperactivity (Propranolol), block new hormone synthesis (PTU or Methimazole), block stored hormone release (Iodine administered at least 1 hour after PTU), and block peripheral conversion (Corticosteroids).
GLP-1 receptor agonists delay gastric emptying, meaning these patients must be managed as having a full stomach with high risk of aspiration during rapid sequence intubation, regardless of fasting duration.
Last updated: October 2026
4.6 Adrenal Crisis and Incretin/Endocrine Emergencies
Endocrine emergencies require rapid recognition and highly structured resuscitation. Flight teams must manage hormonal deficits and severe metabolic derangements while maintaining hemodynamic stability during transport.
Adrenal Crisis (Acute Adrenal Insufficiency)
Cortisol is the primary glucocorticoid, responsible for maintaining vascular sensitivity to catecholamines, stimulating gluconeogenesis, and downregulating the inflammatory response. Aldosterone is the primary mineralocorticoid, responsible for renal sodium conservation and potassium excretion.
Adrenal crisis occurs when there is an acute, life-threatening deficiency of cortisol and aldosterone, often triggered by severe physiological stressors (e.g., infection, trauma, surgery, burns) in a patient with Addison's disease or secondary adrenal insufficiency (e.g., chronic corticosteroid therapy with sudden withdrawal).
Clinical Presentation
Distributive-type shock that is completely refractory to fluids and vasopressors.
Severe hypoglycemia.
Hyponatremia (due to lack of aldosterone causing renal sodium wasting).
Hyperkalemia (due to potassium retention).
Transport Resuscitation
Fluid Management: Aggressive volume resuscitation with D5NS (5% Dextrose in 0.9% Normal Saline). The normal saline corrects the intravascular volume depletion and hyponatremia, while the 5% dextrose corrects the hypoglycemia.
Corticosteroid Replacement:
Dexamethasone: 4 mg IV bolus. Preferred if the diagnosis of adrenal insufficiency is not yet established, because it does not cross-react with serum cortisol assays, allowing diagnostic ACTH stimulation testing in the hospital.
Hydrocortisone: 100 mg IV bolus. Provides both glucocorticoid and mineralocorticoid activity. This is the drug of choice in transport if the diagnosis is established.
Vasopressors: Will be ineffective without corticosteroids. Cortisol is required to restore vascular responsiveness to catecholamines (the permissive effect on alpha-1 receptors).
Hyperglycemic Crises: DKA vs. HHS
- Feature Diabetic Ketoacidosis (DKA) Hyperosmolar Hyperglycemic State (HHS)
- Primary Patient Typically Type 1 Diabetes Typically Type 2 Diabetes
- Insulin Deficiency Absolute Relative (enough to suppress ketogenesis)
- Glucose Level Elevated (typically <600 mg/dL) Markedly elevated (>600 mg/dL, often >1000 mg/dL)
- Acid-Base Status Anion Gap Metabolic Acidosis (pH < 7.30) Normal or mild acidosis (pH > 7.30)
- Ketones Positive (acetoacetate, beta-hydroxybutyrate) Absent or minimal
- Serum Osmolality Variable Elevated (>320 mOsm/kg)
- Fluid Deficit 50–100 mL/kg (Moderate) 100–150 mL/kg (Profound)
- Resuscitation Guidelines
Fluid Resuscitation: The first priority. Administer 1–2 L of 0.9% Normal Saline (or 20 mL/kg in pediatrics). Rapid volume expansion reduces counter-regulatory hormones and lowers blood glucose.
Potassium Management: Insulin drives potassium into cells via the Na+/K+ ATPase pump. Under the 2024 adult consensus, if the serum potassium is <3.5 mEq/L, insulin must be withheld and potassium repleted (about 10 mEq/hr) until the potassium level is >3.5 mEq/L. Starting insulin in a hypokalemic patient can trigger fatal ventricular dysrhythmias. If potassium is 3.5–5.0 mEq/L, add potassium (20–30 mEq/L) to IV fluids. If potassium is >5.0 mEq/L, do not add potassium until it falls below 5.0, and monitor closely.
Insulin Infusion: Infuse regular insulin at 0.1 units/kg/hour (or 0.1 units/kg bolus followed by 0.1 units/kg/hour). Target rate of glucose decline is 75 to 100 mg/dL/hour. If glucose drops too rapidly, the sudden change in serum osmolality can cause water to shift into brain cells, leading to cerebral edema.
Transitioning Fluids: When the blood glucose falls below 250 mg/dL (DKA) or to 300 mg/dL (HHS), add 5–10% dextrose to the IV fluids (e.g., D5 1/2 NS) to allow continued insulin infusion to clear ketones and close the anion gap while preventing hypoglycemia.
Important
Pediatric DKA: High risk of cerebral edema, which is associated with high mortality. Minimize boluses unless in overt shock; rehydrate gradually over 36 to 48 hours. Monitor for signs of cerebral edema (bradycardia, pupillary changes, headache, deteriorating mental status), and treat immediately with Mannitol (0.5–1 g/kg IV over 20 mins) or 3% Hypertonic Saline (5–10 mL/kg over 30 mins).
Thyroid Storm
A rare, life-threatening crisis of extreme thyrotoxicosis. Presentation: Hyperthermia (>40°C), tachycardia/arrhythmias (atrial fibrillation), high-output heart failure, agitation, delirium, and diarrhea.
Multimodal Treatment Sequence (Must be given in order)
Control Sympathetic Hyperactivity: Propranolol (1–2 mg IV slow push, or 60–80 mg PO every 4 hours). It blocks beta-adrenergic receptors and inhibits the peripheral conversion of thyroxine (T4) to the active triiodothyronine (T3).
Block New Hormone Synthesis: Propylthiouracil (PTU, 600–1000 mg PO/NG, then 200–250 mg every 4 hours) or Methimazole (20 mg PO/NG). PTU is preferred because it also blocks peripheral conversion of T4 to T3.
Block Hormone Release: Iodine therapy (Lugol's solution, 5–10 drops PO/NG every 8 hours, or Potassium Iodide). Critical sequence: Iodine must be administered at least 1 hour after PTU or Methimazole. If iodine is given first, the thyroid gland will use it as substrate to synthesize and release more thyroid hormone, worsening the storm (Wolff-Chaikoff effect or Jod-Basedow effect).
Block Peripheral Conversion & Treat Adrenal Insufficiency: Hydrocortisone (100 mg IV every 8 hours) or Dexamethasone (2–4 mg IV every 6 hours).
Supportive Care: Cool the patient actively. Avoid aspirin, which displaces thyroid hormone from thyroid-binding globulin, increasing free T4/T3 levels; use acetaminophen or physical cooling instead.
GLP-1 Receptor Agonists and Transport Airway Management
Glucagon-like peptide-1 (GLP-1) receptor agonists (e.g., semaglutide, liraglutide, tirzepatide) delay gastric emptying. During rapid sequence intubation (RSI) in critical care transport, these patients must be treated as having a full stomach regardless of fasting status. High risk of silent regurgitation and severe aspiration pneumonitis. Transport crews should ensure suction is set up, use a rapid sequence intubation approach with optimal positioning (head-up or ramped), and consider gastric decompression with an orogastric/nasogastric tube after the airway is secured.